Target intelligence / Profile preview

Vibrio cholerae O1 Inaba, classical biotype (V. cholerae O1 Inaba (CL))

Target
V. cholerae O1 Inaba (CL)
Molecular classification
Other
01

Overview

Vibrio cholerae O1 Inaba, classical biotype is a specific strain of the Gram-negative, comma-shaped bacterium that causes cholera, an acute and potentially fatal diarrheal disease (Source [1], [4]). It is characterized by the O1 surface antigen, the Inaba serotype (expressing A and C antigens), and the classical biotype, which is distinguished from the El Tor biotype by its sensitivity to polymyxin B and specific bacteriophages (Source [1], [11]). Historically, this biotype was the primary driver of the first six cholera pandemics, although it has been largely replaced by the El Tor biotype in the ongoing seventh pandemic (Source [7], [11]). The bacterium's pathogenicity is primarily mediated by the secretion of cholera toxin, which binds to GM1 ganglioside receptors on intestinal epithelial cells, leading to a massive efflux of water and electrolytes (Source [1], [7]). Clinical management involves aggressive oral or intravenous rehydration and the use of antibiotics like doxycycline to reduce the duration of illness and bacterial shedding (Source [1], [13]). Furthermore, inactivated whole cells of this specific strain are a critical component of oral cholera vaccines, such as Dukoral, which induce protective mucosal and systemic immunity (Source [3], [5]).

Other names
Vibrio cholerae serogroup O1 serotype Inaba classical biotypeV. cholerae O1 Inaba CLVibrio cholerae classical biotype
02

Mechanism of action

Antibiotics inhibit bacterial growth by targeting ribosomes or DNA replication; vaccines provide inactivated whole-cell antigens to induce protective vibriocidal and anti-toxin antibodies (Source [5], [6], [11]).

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistanceSevere dehydrationElectrolyte imbalance
06

Interacting drugs

Tetracycline

4 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerStool cultureO1 antigen detection

Beyond the preview

Go deeper on Vibrio cholerae O1 Inaba, classical biotype (V. cholerae O1 Inaba (CL)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae O1 Inaba, classical biotype (V. cholerae O1 Inaba (CL)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call